White Jeanette R M, Veltri Michael A, Fackler James C
Investigator Graduate Training Program in Clinical Investigation, the Johns Hopkins School of Medicine, Baltimore, MD, USA.
Pediatr Crit Care Med. 2005 Jan;6(1):25-32. doi: 10.1097/01.PCC.0000149832.76329.90.
To prospectively identify and reduce proximal causes of error contributing to inappropriate intravenous potassium chloride orders and reduce adverse events subsequent to these ordering errors.
Pre-post cohort study of the reduction in both proximal causes of error and number of postinfusion elevated serum potassium levels after intervention.
Sixteen-bed, tertiary care, urban, academic pediatric intensive care unit.
Children 0-18 yrs old receiving intravenous potassium chloride in the pediatric intensive care unit.
A multidisciplinary team determined proximal causes of error that were likely contributors to the occurrence of the outcome measure, elevated potassium levels after intravenous potassium chloride. A mandatory drug request form was designed for physicians ordering intravenous potassium chloride. The drug request form was designed to reduce proximal causes of error and, as a result, elevated potassium levels after intravenous potassium chloride. Demographic and laboratory data on children receiving intravenous potassium chloride in the pediatric intensive care unit and details of the drug order were analyzed.
Data from 1,492 intravenous potassium chloride administration-events before implementation of the drug request form were collected. After the drug request form was mandated, 166 consecutively completed forms were collected and analyzed. The incidence of postinfusion elevations in serum potassium decreased from a rate of 7.7% (103 of 1,341) before the drug request form to 0% (0 of 150) after the drug request form (p < .001). Proximal causes of error were also reduced. The number of patients with a creatinine >/=2 mg/dL receiving intravenous potassium chloride decreased from 28.4% to 14.2% (p < .001). The number of intravenous potassium chloride infusions administered to patients where serum potassium value was >4.5 mmol/L decreased significantly (2.9% vs. 0.0%, p < .02). The incidence rates of both verbal orders and failure to write the order in a correct format were reduced to zero.
Simple, blame-free, system-wide interventions designed to reduce proximal causes of error can be an effective, proactive means of reducing the likelihood of medical morbidity.
前瞻性地识别并减少导致不恰当静脉注射氯化钾医嘱的近端错误原因,并减少这些医嘱错误后的不良事件。
干预前后队列研究,旨在减少近端错误原因以及干预后输注后血清钾水平升高的次数。
拥有16张床位的城市学术性儿科重症监护病房,提供三级医疗服务。
0至18岁在儿科重症监护病房接受静脉注射氯化钾的儿童。
一个多学科团队确定了可能导致结果指标(静脉注射氯化钾后血钾水平升高)出现的近端错误原因。为开具静脉注射氯化钾医嘱的医生设计了一份强制性用药申请表。该用药申请表旨在减少近端错误原因,从而降低静脉注射氯化钾后的血钾水平。分析了儿科重症监护病房接受静脉注射氯化钾儿童的人口统计学和实验室数据以及用药医嘱细节。
收集了在实施用药申请表之前1492次静脉注射氯化钾给药事件的数据。在强制使用用药申请表后,收集并分析了166份连续填写完整的表格。输注后血清钾升高的发生率从用药申请表实施前的7.7%(1341例中的103例)降至用药申请表实施后的0%(150例中的0例)(p < 0.001)。近端错误原因也有所减少。肌酐≥2mg/dL的患者接受静脉注射氯化钾的比例从28.4%降至14.2%(p < 0.001)。血清钾值>4.5mmol/L的患者接受静脉注射氯化钾的次数显著减少(2.9%对0.0%,p < 0.02)。口头医嘱和未以正确格式书写医嘱的发生率均降至零。
旨在减少近端错误原因的简单、无指责的全系统干预措施可以成为降低医疗不良事件发生率的有效、主动手段。